Meningiomas in MG1 had the longest recurrence-free survival, invariably featured NF2 biallelic inactivation due to co-occurring NF2 mutation and 22q loss, lacked other chromosomal alterations, and featured greater immune infiltration and enrichment of pathways involved in immune regulation and signaling [39]. The gene discussed is NF2; the disease is meningioma.